SYBX
SYNLOGIC, INC.
Key Financials
Net Income
$-1005000
↑ 95.7%
Operating Income
$-4008000
↑ 90.2%
Revenue
$0
↓ 100.0%
EPS (Diluted)
$-0.08
↑ 95.8%
Total Liabilities
$3.8M
↓ 35.4%
Total Assets
$15.4M
↓ 22.1%
Shareholders' Equity
$11.9M
↓ 7.0%
Operating Cash Flow
$-4359000.00
↑ 86.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | SYBX |
| Company Name | SYNLOGIC, INC. |
| CIK | 1527599 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 617-659-2802 |